|
|
Volumn 96, Issue 9, 2004, Pages 651-653
|
|
Natural born killers: NK cells drafted into the cancer fight
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELL RECEPTOR;
INTERLEUKIN 2;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
RITUXIMAB;
TRANSFORMING GROWTH FACTOR;
ANTINEOPLASTIC AGENT;
CELL SURFACE RECEPTOR;
MONOCLONAL ANTIBODY;
APOPTOSIS;
B LYMPHOCYTE;
CELL COUNT;
CELL DESTRUCTION;
CELL DIFFERENTIATION;
CELL FUNCTION;
CELL INTERACTION;
CLINICAL TRIAL;
DRUG MECHANISM;
HUMAN;
IMMUNE SYSTEM;
MONOTHERAPY;
NATURAL KILLER CELL;
NONHODGKIN LYMPHOMA;
NOTE;
PRIORITY JOURNAL;
T LYMPHOCYTE;
TUMOR IMMUNITY;
ARTICLE;
GENE;
IMMUNOLOGY;
NEOPLASM;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
GENES, MHC CLASS I;
HUMANS;
INTERLEUKIN-2;
KILLER CELLS, NATURAL;
NEOPLASMS;
RECEPTORS, CELL SURFACE;
|
|
EID: 2442631573
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/96.9.651 Document Type: Note |
|
Times cited : (16)
|
|
References (0)
|